Sign inJoin waitlistJoin the waitlist

Terrence Cescon

Physician · Reading Hospital

Credentials: · · · · ·

History

Reading Hospital
Present

Hematology and Medical Oncology
1991–1994
Hahnemann University Hospital -American Academic Health System
1988–1991
HAHNEMANN UNIV SCH OF MED, PHILADELPHIA
1984–1988

Research

Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial
Familial Cancer · 2013 · 79 citations
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon…
The Cancer Journal · 2010 · 48 citations
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study
Cancer · 2013 · 36 citations

Andre Konski
3 papers
Ana Lopez
2 papers
Charles Geyer
2 papers
Chun Wang
2 papers
Daniel Silver
2 papers
FF
Frederick Fellin
2 papers
Mary Daly
2 papers
Massimo Cristofanilli
2 papers
Maysa Abu-Khalaf
2 papers
Norman Wolmark
2 papers
RJ
Rebecca Jaslow
2 papers
SJ
Samuel Jacobs
2 papers

Clinical trials

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
E-Mindfulness Approaches for Living After Breast Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2039